Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events

• Published in: Archives of toxicology 2022, Vol.96 (1), p.11-78
• Main Authors: Dias-Carvalho, Ana, Ferreira, Mariana, Ferreira, Rita, Bastos, Maria de Lourdes, Sá, Susana Isabel, Capela, João Paulo, Carvalho, Félix, Costa, Vera Marisa
• Format: Article
• Language: English
• Subjects: Attention; Biomedical and Life Sciences; Biomedicine; Brain; Cancer; Cell death; Chemotherapy; Cognitive ability; Cytokines; Environmental Health; Hippocampus; Inflammation; Memory; Metabolism; Morbidity; Neural networks; Neurogenesis; Neurotoxicity; Neurotransmission; Occupational Medicine/Industrial Medicine; Oxidative stress; Patients; Pharmacology/Toxicology; Review Article; Spatial memory; Substantia grisea; Visual perception
• ISSN: 0340-5761; 1432-0738
• DOI: 10.1007/s00204-021-03171-4

Cognitive dysfunction has been one of the most reported and studied adverse effects of cancer treatment, but, for many years, it was overlooked by the medical community. Nevertheless, the medical and scientific communities have now recognized that the cognitive deficits caused by chemotherapy have a strong impact on the morbidity of cancer treated patients. In fact, chemotherapy-induced cognitive dysfunction or ‘chemobrain’  (also named also chemofog) is at present a well-recognized effect of chemotherapy that could affect up to 78% of treated patients. Nonetheless, its underlying neurotoxic mechanism is still not fully elucidated. Therefore, this work aimed to provide a comprehensive review using PubMed as a database to assess the studies published on the field and, therefore, highlight the clinical manifestations of chemobrain and the putative neurotoxicity mechanisms. In the last two decades, a great number of papers was published on the topic, mainly with clinical observations. Chemotherapy-treated patients showed that the cognitive domains most often impaired were verbal memory, psychomotor function, visual memory, visuospatial and verbal learning, memory function and attention. Chemotherapy alters the brain’s metabolism, white and grey matter and functional connectivity of brain areas. Several mechanisms have been proposed to cause chemobrain but increase of proinflammatory cytokines with oxidative stress seem more relevant, not excluding the action on neurotransmission and cellular death or impaired hippocampal neurogenesis. The interplay between these mechanisms and susceptible factors makes the clinical management of chemobrain even more difficult. New studies, mainly referring to the underlying mechanisms of chemobrain and protective measures, are important in the future, as it is expected that chemobrain will have more clinical impact in the coming years, since the number of cancer survivors is steadily increasing.